Windlas Biotech's new GMP-certified injectable facility expands manufacturing capabilities for global pharmaceutical markets.
Foreign banks and wealth managers divided on RBI easing cycle, with differing views on repo rate cuts in 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback